nytimes September 2, 2021 4:00pm House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval #yourfeedscience #alzheimersdisease #aduhelmdrug #biogeninc #foodanddrugadministration #news House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.
nytimes August 31, 2021 10:00am My Stepdad Has Alzheimer’s. Can My Mom Date Someone Else? #marriages #ethicspersonal #alzheimersdisease #news My Stepdad Has Alzheimer’s. Can My Mom Date Someone Else? The magazine’s Ethicist columnist on marriage vows and stolen library books.
nytimes August 25, 2021 2:00pm The Right Kind of Exercise May Boost Memory and Lower Dementia Risk #exercise #alzheimersdisease #dementia #brain #elderly #agechronological #news The Right Kind of Exercise May Boost Memory and Lower Dementia Risk (Published 2019) Being physically fit may sharpen the memory and lower our risk of dementia, even if we do not start exercising until we are older.
nytimes August 25, 2021 2:00pm Brain Booster in a Bottle? Don’t Bother #alzheimersdisease #dietarysupplementsandherbalremedies #brain #dementia #dietandnutrition #exercise #news Brain Booster in a Bottle? Don’t Bother (Published 2019) To support brain health as you age, start with the same foods that can help to keep your heart healthy.
nytimes August 25, 2021 2:00pm How Exercise May Help Keep Our Memory Sharp #memory #exercise #alzheimersdisease #brain #elderly #hormones #dementia #muscles #news How Exercise May Help Keep Our Memory Sharp Irisin, a hormone produced by muscles during exercise, can enter the brain and improve cognition, a mouse study suggests.
nytimes August 23, 2021 4:01pm Seeking Early Signals of Dementia in Driving and Credit Scores #yourfeedscience #alzheimersdisease #testsmedical #memory #elderly #dementia #yourfeedhealth #research #science #news Seeking Early Signals of Dementia in Driving and Credit Scores The pathologies underlying brain decline can begin years before symptoms emerge. Can everyday behavior provide warning?
nytimes July 24, 2021 10:01am For Older Adults, Home Care Has Become Harder to Find #yourfeedscience #homehealthcare #layoffsandjobreductions #laborandjobs #nursinghomes #elderly #alzheimersdisease #coronavirus2019ncov #retirementcommunitiesandassistedliving #yourfeedhealthcare #science #news For Older Adults, Home Care Has Become Harder to Find Staffing shortages have long plagued the home care industry. But the pandemic has intensified the problem.
nytimes July 21, 2021 10:01am We Need to Know How Menopause Changes Women’s Brains #estrogen #menopause #womenandgirls #alzheimersdisease #brain #hormones #elderly #science #news We Need to Know How Menopause Changes Women’s Brains This might turn out to be a crucial window to try to prevent Alzheimer’s and other chronic diseases that often accompany older age.
nytimes July 9, 2021 6:00pm F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval #aduhelmdrug #alzheimersdisease #drugspharmaceuticals #inspectorsgeneral #biogeninc #foodanddrugadministration #woodcockjanet #news F.D.A. Seeks Investigation of Its Own Alzheimer’s Drug Approval The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.
nytimes July 8, 2021 6:01pm In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug #alzheimersdisease #labelingandlabelsproduct #aduhelmdrug #drugspharmaceuticals #clinicaltrials #foodanddrugadministration #biogeninc #science #news In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. Now it recommends that the drug be given only to those with mild symptoms.
nytimes July 7, 2021 2:01pm A New Alzheimer’s Drug Offers More Questions Than Answers #alzheimersdisease #aduhelmdrug #drugspharmaceuticals #elderly #healthinsuranceandmanagedcare #yourfeedhealth #yourfeedscience #science #news A New Alzheimer’s Drug Offers More Questions Than Answers The approval of Aduhelm to treat Alzheimer’s disease has raised hope among older adults, but many doctors wonder if it is warranted.
nytimes June 22, 2021 4:00am Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited #yourfeedscience #alzheimersdisease #aduhelmdrug #drugspharmaceuticals #labelingandlabelsproduct #clinicaltrials #alzheimersassn #biogeninc #foodanddrugadministration #yourfeedhealthcare #news Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited Even those who supported the F.D.A.’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s disease was much too broad.
nytimes June 21, 2021 11:00am The Secrets of ‘Cognitive Super-Agers’ #alzheimersdisease #memory #elderly #brain #agechronological #dementia #news The Secrets of ‘Cognitive Super-Agers’ By studying centenarians, researchers hope to develop strategies to ward off Alzheimer’s disease and slow brain aging for all of us.
nytimes June 15, 2021 12:00pm The F.D.A.'s Approval of Biogen's Alzheimer's Drug Is a New Low #drugspharmaceuticals #aduhelmdrug #alzheimersdisease #foodanddrugadministration #biogeninc #news Opinion | The F.D.A. Has Reached a New Low The F.D.A.'s approval of the Alzheimer's drug aducanumab is inexplicable.
nytimes June 11, 2021 12:00am Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug #yourfeedscience #alzheimersdisease #drugspharmaceuticals #clinicaltrials #aduhelmdrug #elderly #biogeninc #news Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients.
nytimes June 8, 2021 12:00pm Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense #drugspharmaceuticals #alzheimersdisease #healthinsuranceandmanagedcare #clinicaltrials #biogeninc #news Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense Despite scant evidence that it works, the drug, Aduhelm, is predicted to generate billions of dollars in revenue, much of it from Medicare.
nytimes June 7, 2021 10:00pm Industrial Policy, Alzheimer’s, Pizza: Your Monday Evening Briefing #unitedstatespoliticsandgovernment #politicsandgovernment #economicconditionsandtrends #pizza #lawandlegislation #illegalimmigration #incomeinequality #indigenouspeople #immigrationandemigration #alzheimersdisease #news Industrial Policy, Alzheimer’s, Pizza: Your Monday Evening Briefing Here’s what you need to know at the end of the day.
nytimes June 7, 2021 7:00pm F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works #alzheimersdisease #drugspharmaceuticals #foodanddrugadministration #clinicaltrials #biogeninc #news F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works Aducanumab, or Aduhelm, is the first new Alzheimer’s treatment in 18 years and the first to attack the disease process. But some experts say there’s not enough evidence it can address cognitive symptoms.
nytimes June 7, 2021 4:00pm F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works #alzheimersdisease #drugspharmaceuticals #foodanddrugadministration #clinicaltrials #biogeninc #news F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works Aducanumab, or Aduhelm, is the first new Alzheimer’s treatment in 18 years and the first to attack the disease process. But some experts say there’s not enough evidence it can address cognitive symptoms.
nytimes June 6, 2021 1:00am Alzheimer’s Drug Poses a Dilemma for the F.D.A. #alzheimersdisease #drugspharmaceuticals #clinicaltrials #elderly #memory #brain #aducanumabdrug #biogeninc #foodanddrugadministration #alzheimersassn #yourfeedscience #yourfeedhealthcare #news Alzheimer’s Drug Poses a Dilemma for the F.D.A. If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.